Collectively, our results suggest that AP-7 can effectively inhibit the Chk1/CDK1 DNA damage response pathway, thereby reducing DNA damage repair, and enhance the cytotoxicity of DDP in multidrug-resistant NSCLC cells. Here, CDK1 is linked to non-small cell lung carcinoma.